Skip to Main Content

Advertisement

Skip Nav Destination

Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.

J Cell Biol (1995) 131 (6): 1849–1855.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal